Sharon Barber-Lui
Independent Interim ChairMs. Sharon Barber-Lui, C.P.A., M.B.A. is Chief Financial Officer, Senior VP & Director of Teva Pharmaceuticals USA, Inc. Ms. Barber-Lui serves as Independent Non-Executive Director of PureTech Health plc since March 24, 2022 and has been its Interim Chair of the Board since July 2025. She previously led U.S. Oncology Portfolio Market Strategy, Operations and Business Analytics at Merck & Co. Inc. During her time at Merck & Co. Inc., she has held multiple financial and operational positions of increasing responsibility, including Chief Financial Officer of U.S. Oncology, Director of U.S. Treasury Operations and regional Treasurer of Asia Pacific. She currently serves as the Senior Vice President of Global Finance at EQRx since 2022. She has extensive experience in finance, operations, portfolio management and commercialization to PureTech's board of industry, business and academic leaders. She has diverse experiences at Fortune 50 and major public accountancies with strong life science innovation, entrepreneurship and business transformation activity. She also led Portfolio Market Strategy, Operations and Business Analytics at Merck & Co. Inc.'s U.S. Oncology business from 2019 through 2021, where she previously served as Chief Financial Officer of U.S. Oncology from 2014 to 2018. That business portfolio included new, mature, co-developed and co-commercialized products. Ms. Barber-Lui also held a number of other financial and operational related roles throughout the course of her tenure at Merck & Co. Inc. Ms. Barber-Lui received her MBA and her B.S. in accounting from Lehigh University.
Positions
- Company NamePureTech Health plcStock CodePRTCYPositionIndependent Interim Chair
